Loading clinical trials...
Loading clinical trials...
Effects of ROFLUMILAST on Markers of Subclinical Atherosclerosis In Stable COPD; the ELASTIC-trial
Conditions
Interventions
Roflumilast
Placebo
Locations
1
Austria
Deparment for Respiratory and Critical Care Medicine, Otto Wangner Hospital
Vienna, Austria
Start Date
May 1, 2012
Primary Completion Date
January 1, 2016
Completion Date
January 1, 2016
Last Updated
April 12, 2019
Lead Sponsor
LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions